Resistant Hypertension

Slides:

Advertisements

Similar presentations

The British Approach to Antihypertensive Therapy: Guidelines from the National Institute of Health and Clinical Excellence Power Over Pressure

Advertisements

Improving Diagnosis and Management of Hypertension: Implementation of Ambulatory Blood Pressure Monitoring in Primary Care* Scot B. Sternberg, MS; Kristine.

Pharmacological Treatment of Hypertension Update 2012.

Hypertension Guideline

Hypertension In elderly population. JNC VII BP Classification SBP mmHgDBP mmHg Normal

HvC Comparative Effectiveness Project Groups 5 and 6

Thiazide diuretics, Potassium, and the Development of Diabetes A Quantitative Review Hypertension2006_219.

A Controlled Trial of Renal Denervation for Resistant Hypertension

HIGH BLOOD PRESSURE (HYPERTENSION) RAKAN ASSAF M. AL-ASSAF

Introduction. Adult ADHD in the Real World: From Clinical Trials to Clinical Practice.

Update on therapy-resistant hypertension:

Thomas G. Pickering, MD, DPhil, William B. White, MD

A 45-year-old man has recently been diagnosed with hypertension and started on monotherapy designed to reduce peripheral resistance and prevent NaCl and.

Hypertension treatment guidelines from the United Kingdom’s National Institute for Health and Care Excellence. Guidelines identify angiotensin-converting.

From ESH 2016 | POS 7D: Jan Rosa, MD

RESISTANT HYPERTENSION OR POOR PATIENT ADHERENCE? TIPS TO GAIN CONTROL

Clinical Considerations in the Management of EGFR-Mutated Advanced NSCLC.

Acute Heart Failure.

Access to NOAC Therapy:

At The Cutting Edge of Developments in the Management of Hyperkalemia

Modern Strategies for Basal Insulin Use in T2D

Select Topics in Cardiovascular Medicine

Medication Nonadherence in Gout

Managing Complex Hypertension: What Every Physician Should Know

Section VIII. Ambulatory BP Measurement

How to Achieve Aggressive BP Goals in Difficult-to-Treat Patients

Optimizing Outcomes in the Management of GIST

SGLT2 Inhibitors in the Modern Era: Why and Where?

Examining CV Effects of Basal Insulin Therapy

Managing Hard-To-Treat Hypertension: What Every Physician Should Know

Strategies to Improve Adherence and Persistence in the Treatment of Hypertension.

Surveying the Safety of NOACs in the Real World

Resistant Hypertension: Initial Combinations of Medications

Panelists. One Size May Not Fit All: A New Aspirin Option for the High-Risk Patient.

Clinical Considerations in Evidence-based Management of GIST

Hypertension Guidelines

Blood pressure control: dependence on adherence

Treating Vasodilatory Shock in the ICU

Talking to Patients About Diabetes Management

Clinical Updates in RA: New Developments and Insights From Washington

Case Study. Managing Medication and Adherence in SIHD: Partnering With the Patient to Improve Care.

What's New in Dyslipidemia?

Introduction. A Reality Check on BP Goals and Optimizing Patient Adherence to Treatment.

Access to NOAC Therapy:

Expert Insights on Complex Clinical Cases of Edema

Poor Response to Initial Therapy for Migraine

Controlling High Blood Pressure

NOACs in AF: Consequences of Underdosing and NonAdherence

Management of Systematic Lupus Erythematosus

Novel Insulin/GLP-1 Combinations: Of Interest to the Primary Care Physician?

Tackling Schizophrenia With Your Patients

Managing Age-Related Clinical Issues in Hemophilia

A 45-year-old man has recently been diagnosed with hypertension and started on monotherapy designed to reduce peripheral resistance and prevent NaCl and.

Critical Decision Points in Insomnia

Controlling Elevated Blood Pressure

A Nursing Perspective on Improving Outcomes for Patients With Hemophilia.

NOACs in AF: Consequences of Underdosing and NonAdherence

Managing CLL With BTK Inhibitors

Improving Adherence to Antiplatelet Therapy After an ACS Event

Program Goal. Program Goal Disclaimer Overview.

AMD Therapy: Where Are We Now and Where Are We Going?

Pharmacological Treatment of Hypertension Update 2012

Clinical Considerations in Evidence-based Management of GIST

Binge Eating Disorder.

Clinical Comparisons in CTEPH

My PAH Patient.

Pathway to initial antihypertensive therapy in patients with diabetes

What's New in NOACs in AF?.

Average change in blood pressure (BP) from recruitment to 6-month postrecruitment in intervention and control patients >50 years included due to having.

Presentation transcript:

Resistant Hypertension

Prevalence of Resistant Hypertension

Factors That May Influence Prevalence of Resistant Hypertension in Clinical Practice

Spanish ABPM Registry 24-Hour ABPM Identifies Patients With “True” Resistant Hypertension

JNC 7 Supports Combination Therapy

JNC 8 Supports Combination Therapy

Which “Thiazide” to Use?

Chlorthalidone Representative Outcome Studies

Chlorthalidone + Azilsartan Provides Better Blood Pressure Reduction than Hydrochlorothiazide + Azilsartan

Switching From Hydrochlorothiazide to Chlorthalidone at Same Dose Controls Resistant Hypertension

Treatment of Resistant Hypertension

Medication Adherence Next Frontier in Quality Improvement

Nonadherence to Antihypertensive Therapies

Association Between Medication Adherence and Costs

Interventions to Improve Antihypertensive Medication Adherence Systematic Review of RCTs

Abbreviations

Abbreviations (cont)

References

References (cont)

References (cont)

References (cont)

References (cont)

References (cont)